Interaction of the alpha-adrenoceptor agonist oxymetazoline with serotonin 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors.
P Schoeffter, D Hoyer
Index: Eur. J. Pharmacol. 196 , 213, (1991)
Full Text: HTML
Abstract
Oxymetazoline was recognized with nanomolar affinity by 5-HT1A, 5-HT1B and 5-HT1D binding sites and mimicked the effects of 5-hydroxytryptamine with about the same potency and intrinsic activity as the endogenous amine in the corresponding functional tests. At 5-HT1C receptors, oxymetazoline behaved as a mixed agonist-antagonist. Clonidine had minimal activity. Methiothepin antagonized the effects of oxymetazoline (7.4 less than pKB less than 8.8). Thus, oxymetazoline is a full and potent agonist at 5-HT1A, 5-HT1B and 5-HT1D receptors and a partial agonist at 5-HT1C receptors.
Related Compounds
Related Articles:
2013-01-01
[Acta Pol. Pharm. 70(6) , 1079-85, (2013)]
1995-09-01
[Br. J. Pharmacol. 116 , 1611, (1995)]
Benzylimidazolines as h5-HT1B/1D serotonin receptor ligands: a structure-affinity investigation.
1998-06-18
[J. Med. Chem. 41 , 2243-2251, (1998)]